Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside

被引:4
作者
Goettl, VM
Wemlinger, TA
Fong, TG
Neff, NH
Hadjiconstantinou, M [1 ]
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Pharmacol, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Dept Psychiat, Columbus, OH 43210 USA
关键词
retina; aging; dopamine; tyrosine hydroxylase; mazindol binding; choline acetyltransferase; hemicholinium-3; binding; GM1; ganglioside;
D O I
10.1016/S0006-8993(00)02598-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Selected cholinergic and dopaminergic markers were compared in the retina of aged (20-22-months-old) and young (3-months-old) rats before and after treatment with GM1 ganglioside. The dopaminergic markers, tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid were comparable in the young and aged animals and GM1 treatment did not alter them. In contrast, mazindol binding, a marker fur the dopamine transporter, was diminished in the aged retina and treatment with GM1 restored binding to values found in the young animals. The cholinergic markers choline acetyltransferase and hemicholinium-3 binding, a marker for the high-affinity choline transport, were depressed in aged rats and GM1 corrected the deficits. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [21] GM1 increases the content and mRNA of NGF in the brain of aged rats
    Duchemin, AM
    Neff, NH
    Hadjiconstantinou, M
    NEUROREPORT, 1997, 8 (17) : 3823 - 3827
  • [22] Effects of chronic GM1 ganglioside treatment on cognitive and motor deficits in a slowly progressing model of Parkinsonism in non-human primates
    Pope-Coleman, A
    Schneider, JS
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 1998, 12 (04) : 255 - 266
  • [23] Anti-Inflammatory Effects of GM1 Ganglioside on Endotoxin-Induced Uveitis in Rats
    Weng, Tzu-Heng
    Ke, Chang-Chih
    Huang, Yuahn-Sieh
    BIOMOLECULES, 2022, 12 (05)
  • [24] A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease
    Schneider, J. S.
    GLYCOCONJUGATE JOURNAL, 2022, 39 (01) : 13 - 26
  • [25] A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease
    J. S. Schneider
    Glycoconjugate Journal, 2022, 39 : 13 - 26
  • [26] EFFECTS OF GM1 GANGLIOSIDE ON CARDIAC-FUNCTION FOLLOWING EXPERIMENTAL HYPOXIA-REOXYGENATION
    LODOVICI, M
    DOLARA, P
    AMERINI, S
    MANTELLI, L
    LEDDA, F
    BENNARDINI, F
    FAZI, M
    MONTEREGGI, A
    DINI, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 243 (03) : 255 - 263
  • [28] Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Aβ1-42-Induced Neurotoxicity and Cognitive Deficits
    Dai, Ruwei
    Zhang, Shijie
    Duan, Wenjun
    Wei, Renrong
    Chen, Huifang
    Cai, Weibin
    Yang, Lei
    Wang, Qi
    NEUROCHEMICAL RESEARCH, 2017, 42 (08) : 2417 - 2426
  • [29] Alzheimer disease -: Effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme
    Svennerholm, L
    Bråne, G
    Karlsson, I
    Lekman, A
    Ramström, I
    Wikkelsö, C
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 14 (03) : 128 - 136
  • [30] Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 ganglioside
    Wu, Gusheng
    Lu, Zi-Hua
    Seo, Joon Ho
    Alselehdar, Samar K.
    DeFrees, Shawn
    Ledeen, Robert W.
    EXPERIMENTAL NEUROLOGY, 2020, 329